Hot on HuffPost Healthy Living:

 

Wyeth sees new competition for Effexor anti-depressant drug

Posted on Dec 20th 2007 7:22PM by Brian White
Effexor, the best-selling anti-depression drug in the world (sales) may now have a new competitor. In what could happen more and more, an Indian pharmaceutical company has applied to the FDA to sell a drug in pill form instead of capsule.

The dinger: the new drug, which will be sold as a generic, will have the same active ingridient at Wyeth's $3.7 billion-a-year Effexor drug. Think that's a threat? Sure -- big-time.

The difference here that makes this potential new anti-depressant such a big deal is because it comes in an extended-release tablet as opposed to a capsule (which is under Wyeth patent protection until 2010). Nothing like finding a loophole for new drug sales, huh?

Around the Web

 
 
 

Share Your Success Story

Jupiter Images

Have you lost weight and kept it off? We want to know how you did it and what keeps you inspired!